Related Experiment Video
Updated: Feb 13, 2026

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR
Published on: November 4, 2016
Characterization of the Lytic Capability of a LysK-Like Endolysin, Lys-phiSA012, Derived from a Polyvalent
Jumpei Fujiki1, Tomohiro Nakamura2, Takaaki Furusawa3
1Laboratory of Biochemistry, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan. j-fujiki@rakuno.ac.jp.
Abstract:
Antibiotic-resistant bacteria (ARB) have spread widely and rapidly, with their increased occurrence corresponding with the increased use of antibiotics. Infections caused by Staphylococcus aureus have a considerable negative impact on human and livestock health. Bacteriophages and their peptidoglycan hydrolytic enzymes (endolysins) have received significant attention as novel approaches against ARB, including S. aureus. In the present study, we purified an endolysin, Lys-phiSA012, which harbors a cysteine/histidine-dependent amidohydrolase/peptidase (CHAP) domain, an amidase domain, and a SH3b cell wall binding domain, derived from a polyvalent S. aureus bacteriophage which we reported previously. We demonstrate that Lys-phiSA012 exhibits high lytic activity towards staphylococcal strains, including methicillin-resistant S. aureus (MRSA). Analysis of deletion mutants showed that only mutants possessing the CHAP and SH3b domains could lyse S. aureus, indicating that lytic activity of the CHAP domain depended on the SH3b domain. The presence of at least 1 mM Ca2+ and 100 µM Zn2+ enhanced the lytic activity of Lys-phiSA012 in a turbidity reduction assay. Furthermore, a minimum inhibitory concentration (MIC) assay showed that the addition of Lys-phiSA012 decreased the MIC of oxacillin. Our results suggest that endolysins are a promising approach for replacing current antimicrobial agents and may contribute to the proper use of antibiotics, leading to the reduction of ARB.
Insights
This study purified an endolysin, Lys-phiSA012, effective against antibiotic-resistant bacteria like methicillin-resistant Staphylococcus aureus. The endolysin’s activity is enhanced by specific ions and can reduce antibiotic minimum inhibitory concentrations.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Antibiotic-resistant bacteria (ARB) pose a significant global health threat, exacerbated by widespread antibiotic use.
- Staphylococcus aureus infections, including methicillin-resistant strains (MRSA), cause substantial harm to human and livestock health.
- Bacteriophage-derived enzymes (endolysins) are emerging as promising alternatives to conventional antibiotics against ARB.
Purpose of the Study:
- To characterize a novel endolysin, Lys-phiSA012, derived from a Staphylococcus aureus bacteriophage.
- To evaluate the lytic activity of Lys-phiSA012 against staphylococcal strains, including MRSA.
- To investigate the role of specific domains and metal ions in the endolysin's activity and its potential to reduce antibiotic resistance.
Main Methods:
- Purification and characterization of the endolysin Lys-phiSA012, featuring CHAP, amidase, and SH3b domains.
- Lytic activity assays using turbidity reduction to assess the endolysin's efficacy against staphylococcal strains.
- Deletion mutant analysis to determine the functional contribution of each domain.
- Minimum inhibitory concentration (MIC) assays to evaluate the combined effect of the endolysin and oxacillin.
Main Results:
- Lys-phiSA012 demonstrated potent lytic activity against various staphylococcal strains, including MRSA.
- The cysteine/histidine-dependent amidohydrolase/peptidase (CHAP) and SH3b domains were essential for the endolysin's lytic function.
- Lytic activity was significantly enhanced by the presence of calcium (Ca2+) and zinc (Zn2+) ions.
- Co-administration of Lys-phiSA012 with oxacillin reduced the MIC of oxacillin, indicating a synergistic effect.
Conclusions:
- Endolysin Lys-phiSA012 is a potent antimicrobial agent effective against antibiotic-resistant Staphylococcus aureus.
- The combination of CHAP and SH3b domains is crucial for the lytic activity of Lys-phiSA012.
- Metal ion supplementation can potentiate endolysin efficacy.
- Endolysins represent a viable strategy to combat ARB and promote judicious antibiotic use.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
DNA Bacteriophages
Viral Replication: Lytic Cycle
Measurement: Derived Units
Higher Derivatives

